Low
₹1,112.10
High
₹1,183.10
| Previous Close | ₹1,173.40 |
|---|---|
| Day's Range | ₹1,112.10 - ₹1,183.10 |
| Open | ₹1,116.20 |
| 52 Week Range | ₹956.00 - ₹1,456.50 |
| Volume | 1,14,426 |
| Market Cap | ₹0.03 |
| Previous Close | ₹1,175.30 |
|---|---|
| Day's Range | ₹1,110.05 - ₹1,182.00 |
| Open | ₹1,110.05 |
| 52 Week Range | ₹955.20 - ₹1,455.85 |
| Volume | 2,77,712 |
| Market Cap | ₹0.03 |
| Trade Value ( ₹ in Lacs) | 1,342.67 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.04 |
| Price/Earning (TTM) | 58.47 |
| TTM EPS (₹) | 19.11 |
| P/E Ratio | 66.85 |
| Book Value(₹) | 7.89 |
| PAT Margin (%) | 13.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 20.50 |
| Trade Value ( ₹ in Lacs) | 3,263.95 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.04 |
| Price/Earning (TTM) | 58.47 |
| TTM EPS (₹) | 19.11 |
| P/E Ratio | 66.85 |
| Book Value(₹) | 7.89 |
| PAT Margin (%) | 13.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 20.50 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 9434.36 | 32751.11 |
| Expenses | N/A | N/A |
| PBT | 1890.68 | 6270.99 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1428.58 | 4780.6 |
| Founded | 2004 |
|---|---|
| Managing Director | Naresh Trehan |
| NSE Symbol | MEDANTA |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,33,847.75 | 1,823.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,72,696.60 | 6,594.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,41,859.41 | 4,257.30 | 3,101.60 - 3,101.60 |
| Dr. Reddy's Laboratories Ltd. | 1,10,420.94 | 1,305.55 | 1,129.40 - 1,129.40 |
| Apollo Hospitals Enterprise Ltd. | 1,09,839.98 | 7,776.20 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,05,811.45 | 1,328.30 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,05,320.35 | 2,357.35 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 96,662.57 | 1,013.60 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 92,743.95 | 2,279.95 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 89,720.85 | 901.05 | 835.50 - 835.50 |
No Records Found
Posted on May 4th
OneSource Specialty Pharma informs about press release
Posted on May 4th
Govt reports 8.7% growth in GST collection for April
Posted on May 2nd
Value 360 Communications coming with IPO to raise up to Rs 41.69 crore
Posted on Apr 30th
Currency futures for May expiry trade weaker with 4.93% increase in OI
No Records Found
Pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Global Health has informed that it enclosed the copies of Newspaper clippings of the Unaudited Financial Results of the Company, for the Third Quarter and Nine Months ended December 31, 2025, published in Financial Express (English) and Jansatta (Hindi) on Thursday, February 05, 2026.
The above information is a part of company’s filings submitted to BSE.
Modern Diagnostic & Research Centre has informed that it enclosed, a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the half year ended March 31, 2026, received from MUFG Intime India (Formerly known as Link Intime India), Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Global Health Ltd. is ₹1,173.40 as of 2026-05-04.
The market capitalisation of Global Health Ltd. is ₹30,048.23 as of 2026-04-30.
The 1-year return of Global Health Ltd. is 56.15% as of 2026-05-04.
The P/E ratio of Global Health Ltd. is 66.85 as of 2026-05-04.
The 52-week high and low of Global Health Ltd. are ₹1,456.50 and ₹956.00, respectively, as of 2026-05-04.
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.